Hua Ling Pharmaceuticals-B (02552.HK) expects a mid-term profit of about 1.184 billion yuan, with improved efficiency in commercialization and transition.

According to the economic and financial news app, Horizon Healthcare-B (02552.HK) issued a positive profit forecast on July 28th, showing an expected net profit of approximately 1.184 billion yuan for the six months ending June 30, 2025. The company achieved strong growth in the first half of 2025, mainly due to improved efficiency in commercialization transfer and sales growth.